A higher rate of serrated polyp detection was associated with a reduced risk of post colonoscopy colorectal cancer, based on data from nearly 20,000 patients and 142 endoscopists, according to a study published in Gastrointestinal Endoscopy. Higher rates of adenoma detection reduce the risk of post colonoscopy colorectal cancer (PCCRC), but the data on detection rates for clinically significant serrated polyps and traditional serrated adenomas are limited, wrote Joseph C. Anderson, MD, of the Geisel School of Medicine at Dartmouth, Hanover, N.H., and colleagues.
Author: Praveen Suthrum
The news: Digital health marketplace Solera Health is partnering with Oshi Health and Vivante Health to expand its digital chronic disease management programs to incorporate individually tailored digestive health solutions for patients. More on Solera: Solera is a health benefits network that connects patients, payers, and providers with digital health and SDOH-focused offerings. It currently offers digital therapy solutions for a range of chronic conditions like diabetes, as well as mental health, musculoskeletal conditions, and tobacco cessation.Its SDOH efforts include services that address social isolation and loneliness.
With all of the new GI tech surfacing, there are three innovations one expert is following. Michael Wallace, MD, chief of gastroenterology and hepatology at Mayo Clinic/Sheikh Shakhbout Medical City in Abu Dhabi, spoke with Becker’s to discuss what technology gastroenterologists should keep tabs on. Editor’s note: This was edited lightly for clarity and brevity.
EmTech Digital is MIT Technology Review’s Signature AI Conference. Here are my takeaways from Day 2: Envisioning the next AI and more. Note: These aren’t comprehensive and by no means cover the depth of insights that speakers gave. These are just a few things that I’m geeked about. Read Part 1: Takeaways from #EmTech Digital (1) – Better Data, Better AI What’s next for deep learning? AI is becoming another cloud-based service. Can use off-the-shelf? Example, large language AIs.
April 05, 2022 – Hospitals saw higher operating margins, decreases in costs per adjusted discharges, and increased inpatient utilization following private equity acquisitions, according to a Health Affairs study sent to journalists. Private equity firms have been acquiring physician practices, hospitals, and laboratory facilities at high rates in recent years. These acquisitions have received mixed reviews from the industry on whether they benefit health systems.
Gastro Health, a national leading medical group specializing in digestive and liver health, has partnered with two practices in Maryland and Washington where Gastro Health already has an existing presence. Goldberg, Rosenstein, Khan & Forman, M.D., P.A., located in Towson, Maryland, will become the third Gastro Health practice in the state bringing its presence to four office locations with a combined 27 providers.
Background Artificial intelligence (AI) tools increase detection of precancerous polyps during colonoscopy and might contribute to long-term colorectal cancer prevention. The aim of the study was to investigate the incremental effect of the implementation of AI detection tools in screening colonoscopy on colorectal cancer incidence and mortality, and the cost-effectiveness of such tools.
Alerts generated by electronic health records are intended to benefit patient health and safety, but the abundance of “red flags” that physicians see each day can have a desensitizing effect. There may be better ways to set up alerts that improve patient care without the added stress.
CAMBRIDGE, Mass.–(BUSINESS WIRE)– Iterative Scopes, a pioneer in precision medicine technologies for gastroenterology, announced today that two new members have joined the leadership team: Brice Wu as Chief Product Officer, and Haig Soghigian as Vice President of the newly formed Customer Success team. They collectively bring more than 20 years’ experience leading technical and customer service teams across a number of industries including healthcare and life sciences.
Anxiety and depression are common among individuals with inflammatory bowel disease (IBD) who are in remission, and the conditions are linked to unemployment and presenteeism, according to a prospective study.